Characterization of individual bile acids <i>in vivo</i> utilizing a novel low bile acid mouse modelRulaiha Taylor, Grace L. Guo, Laurie B. Joseph et al.|Toxicological Sciences|2024Cited by 10
Effects of therapeutically approved individual bile acids on the development of metabolic dysfunction-associated steatohepatitis a low bile acid mouse modelRulaiha Taylor, Grace L. Guo, Veronia Basaly et al.|Toxicological Sciences|2024Cited by 6
Ursodeoxycholic acid acts as an ileal FXR agonist in male mice with hepatic deficiency of FXRZakiyah Henry, Grace L. Guo, Syeda Maliha et al.|eGastroenterology|2025Cited by 3
Deletion of hepatic FXR leads to more severe MASH development in female mice.Zakiyah Henry, Grace L. Guo, Laura E. Armstrong et al.|PubMed|2025Cited by 2
Mutation of PXR phosphorylation motif at Ser347 disrupts lipid and bile acid homeostasis in diet-induced metabolic dysfunction–associated steatohepatitis in miceVeronia Basaly, Grace L. Guo, Zakiyah R. Henry et al.|Drug Metabolism and Disposition|2025Cited by 0